Vision Improvement for Patients With Age-Related Macular Degeneration

ConditionMacular Degeneration

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age50-100

SponsorVIS, Inc.

About this trial

This study is being conducted to assess the safety and efficacy of the VIS, LLC (VIS) Opti-K Low Vision Aid Device and treatment to provide vision improvement to patients with age-related macular degeneration.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Male or Female

Any race

Patient is at least 50 years old.

Patient has diagnosed end stage dry or wet age-related macular degeneration in one or both eyes, as verified by a complete ocular examination.

Disqualifiers

Corneal disease or corneal disorder in either eye.

Pathological retinal morphology in either eye that completely affects the entire 10° (3 mm diameter) of the retina centered on the foveola.

Gonzalez-Markowitz chart Potential Visual Acuity (PVA) in the eye to be treated that is not improved by at least four lines compared to CDVA;

Increased IOP (above 20 mm Hg), glaucoma or history of glaucoma;

Trial design

Design model

Single group

Treatments tested in this trial

Vision Improvement
Procedure/Surgery
Laser Vision Improvement for Patients with Age-Related Macular Degeneration

Treatment groups

200 Participants

are divided into 1 treatment group

Group A: Vision ImprovementExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

Visual Acuity

Standard measurements of visual acuity before and after treatment

Time frame

1 year

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

VIS, Inc.

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: